SEARCH

SEARCH BY CITATION

References

  • Akar, Z., N. Tanriover, S. Tuzgen, B. Canbaz, H. Erman, B. Oz, et al. 2002. Intracerebral Whipple disease: unusual location and bone destruction. Case report. J. Neurosurg. 97:988991.
  • Anderson, M. 2000. Neurology of Whipple's disease. J. Neurol. Neurosurg. Psychiatry 68:25.
  • de Andrade, D. C., R. C. Nogueira, L. T. Lucato, P. E. Marchiori, L. R. Machado, M. J. Teixeira, et al. 2007. Isolated CNS Whipple disease with a variant of oculofacial-skeletal myorhythmia (OFSM). Neurology 69:E12.
  • Benito-Leon, J., J. Arpa, E. D. Louis, I. Herrera, and A. De La Loma. 2007. Isolated CNS Whipple disease: acute onset and relapsing-remitting course. Scand. J. Infect. Dis. 39:623625.
  • Benito-Leon, J., L. F. Sedano, and E. D. Louis. 2008. Isolated central nervous system Whipple's disease causing reversible frontotemporal-like dementia. Clin. Neurol. Neurosurg. 110:747749.
  • Black, D. F., A. J. Aksamit, and J. M. Morris. 2010. MR imaging of central nervous system Whipple disease: a 15-year review. AJNR Am. J. Neuroradiol. 31:14931497.
  • Burkhard, P. R., J. C. Sanchez, T. Landis, and D. F. Hochstrasser. 2001. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 56:15281533.
  • De Coene, B., C. Gilliard, P. Indekeu, T. Duprez, and J. P. Trigaux. 1996. Whipple's disease confined to the central nervous system. Neuroradiology 38:325327.
  • Dobbins, W. O., III, and J. M. Ruffin. 1967. A light- and electron-microscopic study of bacterial invasion in Whipple's disease. Am. J. Pathol. 51:225242.
  • Durand, D. V., C. Lecomte, P. Cathebras, H. Rousset, and P. Godeau. 1997. Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Medicine (Baltimore) 76:170184.
  • Fahn, S., J. Jankovic, and M. Hallett. 2011. Principles and practice of movement disorders. 2nd ed. Elsevier/Saunders, Edinburgh, New York.
  • Famularo, G., G. Minisola, and C. De Simone. 2005. A patient with cerebral Whipple's disease and a stroke-like syndrome. Scand. J. Gastroenterol. 40:607609.
  • Fenollar, F., X. Puechal, and D. Raoult. 2007. Whipple's disease. N. Engl. J. Med. 356:5566.
  • Feurle, G. E., and T. Marth. 1994. An evaluation of antimicrobial treatment for Whipple's disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig. Dis. Sci. 39:16421648.
  • Fleming, J. L., R. H. Wiesner, and R. G. Shorter. 1988. Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin. Proc. 63:539551.
  • Gerard, A., F. Sarrot-Reynauld, E. Liozon, P. Cathebras, G. Besson, C. Robin, et al. 2002. Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine (Baltimore) 81:443457.
  • Grossman, R. I., K. R. Davis, and J. Halperin. 1981. Cranial computed tomography in Whipple's disease. J. Comput. Assist. Tomogr. 5:246248.
  • Halperin, J. J., D. M. Landis, and G. M. Kleinman. 1982. Whipple disease of the nervous system. Neurology 32:612617.
  • Hausser-Hauw, C., E. Roullet, R. Robert, and R. Marteau. 1988. Oculo-facio-skeletal myorhythmia as a cerebral complication of systemic Whipple's disease. Mov. Disord. 3:179184.
  • Keinath, R. D., D. E. Merrell, R. Vlietstra, and W. O. Dobbins III. 1985. Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients. Gastroenterology 88:18671873.
  • Kenney, K., C. Brechtel, H. Takahashi, K. Kurohara, P. Anderson, and C. J. Gibbs Jr. 2000. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann. Neurol. 48:395398.
  • Knopman, D. S., S. T. DeKosky, J. L. Cummings, H. Chui, J. Corey-Bloom, N. Relkin, et al. 2001. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:11431153.
  • Lemstra, A. W., M. T. van Meegen, J. P. Vreyling, P. H. Meijerink, G. H. Jansen, S. Bulk, et al. 2000. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients. Neurology 55:514516.
  • Louis, E. D., T. Lynch, P. Kaufmann, S. Fahn, and J. Odel. 1996. Diagnostic guidelines in central nervous system Whipple's disease. Ann. Neurol. 40:561568.
  • Marth, T. 2001. The diagnosis and treatment of Whipple's disease. Curr. Allergy Asthma Rep. 1:566571.
  • Marth, T. 2009. New insights into Whipple's disease – a rare intestinal inflammatory disorder. Dig. Dis. 27:494501.
  • Matthews, B. R., L. K. Jones, D. A. Saad, A. J. Aksamit, and K. A. Josephs. 2005. Cerebellar ataxia and central nervous system Whipple disease. Arch. Neurol. 62:618620.
  • Panegyres, P. K., R. Edis, M. Beaman, and M. Fallon. 2006. Primary Whipple's disease of the brain: characterization of the clinical syndrome and molecular diagnosis. QJM 99:609623.
  • Peoc'h, K., H. C. Schroder, J. Laplanche, S. Ramljak, and W. E. Muller. 2001. Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay. Neurosci. Lett. 301:167170.
  • Peters, G., D. G. du Plessis, and P. R. Humphrey. 2002. Cerebral Whipple's disease with a stroke-like presentation and cerebrovascular pathology. J. Neurol. Neurosurg. Psychiatry 73:336339.
  • Revilla, F. J., R. de la Cruz, N. Khardori, and A. J. Espay. 2008. Teaching NeuroImage: oculomasticatory myorhythmia: pathognomonic phenomenology of Whipple disease. Neurology 70:e25.
  • Saiz, A., C. Marin, E. Tolosa, and F. Graus. 1998. Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease. Neurologia 13:324328.
  • Saiz, A., F. Graus, J. Dalmau, A. Pifarre, C. Marin, and E. Tolosa. 1999. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann. Neurol. 46:774777.
  • Scheld, W. M. 2003. Whipple disease of the central nervous system. J. Infect. Dis. 188:797800.
  • Schneider, T., V. Moos, C. Loddenkemper, T. Marth, F. Fenollar, and D. Raoult. 2008. Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect. Dis. 8:179190.
  • Schnider, P., S. Trattnig, H. Kollegger, and E. Auff. 1995. MR of cerebral Whipple disease. AJNR Am. J. Neuroradiol. 16:13281329.
  • Schnider, P. J., E. C. Reisinger, W. Gerschlager, C. Muller, T. Berger, G. J. Krejs, et al. 1996. Long-term follow-up in cerebral Whipple's disease. Eur. J. Gastroenterol. Hepatol. 8:899903.
  • Schwartz, M. A., J. B. Selhorst, A. L. Ochs, R. W. Beck, W. W. Campbell, J. Harris, et al. 1986. Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease. Ann. Neurol. 20:677683.
  • La Scola, B., F. Fenollar, P. E. Fournier, M. Altwegg, M. N. Mallet, and D. Raoult. 2001. Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus. Int. J. Syst. Evol. Microbiol. 51:14711479.
  • Sieracki, J. C., G. Fine, R. C. Horn Jr., and J. Bebin. 1960. Central nervous system involvement in Whipple's disease. J. Neuropathol. Exp. Neurol. 19:7075.
  • Simpson, D. A., R. Wishnow, R. B. Gargulinski, and A. M. Pawlak. 1995. Oculofacial-skeletal myorhythmia in central nervous system Whipple's disease: additional case and review of the literature. Mov. Disord. 10:195200.
  • Verhagen, W. I., P. L. Huygen, J. E. Dalman, and M. M. Schuurmans. 1996. Whipple's disease and the central nervous system. A case report and a review of the literature. Clin. Neurol. Neurosurg. 98:299304.
  • Verhagen, W. I., P. L. Huygen, and J. E. Dalman. 1997. Central nervous system Whipple's disease. Ann. Neurol. 41:560561.
  • Zerr, I., M. Pocchiari, S. Collins, J. P. Brandel, J. de Pedro Cuesta, R. Knight, et al. 2000. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55:811815.